CCL Products (India) Limited (CCL)

Fast Moving Consumer Goods · Agricultural Food & other Products · NSE · Updated 15 July 2026
₹1,223 ↑ 37.68% (1Y)

🎯 Key Takeaways

  • CCL Products (India) Limited is in a high-growth phase driven by strong volume expansion, premiumization, and international market penetration, particularly in the UK. Management is focused on sustaining 15% volume and EBITDA growth in FY27, supported by strategic capacity expansion and D2C channel development.
  • Revenue grew 2.7% QoQ to ₹758 in Q3FY25.
  • ⚠️ 1) Input cost volatility, particularly in raw materials, could pressure margins despite current efficiency gains. 2) Execution risks in international
Market Cap
₹14,906
P/E Ratio
54.3
Div Yield
0.00%
Promoter
0.0%

📖 The Story

CCL Products (India) Limited is in a high-growth phase driven by strong volume expansion, premiumization, and international market penetration, particularly in the UK. Management is focused on sustaining 15% volume and EBITDA growth in FY27, supported by strategic capacity expansion and D2C channel development. The company has demonstrated consistent top-line growth and improving profitability, with net profit margins expanding over the past year despite cyclical input cost pressures.

📰 What's Happening

In Q4 FY26, CCL reported a 46% YoY revenue increase to ₹1,226.39 crores and a 12% YoY rise in net profit to ₹114.53 crores, with full-year revenue up 43% and net profit up 25%. Volume growth of 18-20% YoY was led by strong performance in the direct-to-consumer (D2C) segment, now contributing 20-25% of sales. Management highlighted ongoing capacity expansion, premium brand development, and international growth, especially in the UK. The company also exercised and granted new stock options in May-June 2026 as part of employee compensation strategy, and reaffirmed its focus on strategic acquisitions or partnerships for future growth without planned capex in the next two years.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue520655608664727773738758
Operating Profit115107111112122132138127
OPM %21.7%16.2%18.1%16.7%16.3%16.9%18.6%16.4%
Net Profit8561616365717463
EPS₹6.41₹4.56₹4.57₹4.76₹4.90₹5.37₹5.55₹4.73

Revenue has grown consistently over the past four quarters, rising from ₹520 crores in Q4FY23 to ₹1,226.39 crores in Q4FY26, reflecting expanding market share and demand. Operating margins have stabilized around 16-18% in recent quarters, with EBITDA growing 32% YoY in FY26 to ₹741.38 crores, indicating improved operational efficiency. Net profit margins have shown resilience, supported by cost discipline and scale benefits, while EBITDA margins remain robust at 16% in Q4FY26. The company has reduced net debt to ₹1,073 crores, enhancing financial flexibility amid sustained growth.

🔮 Management Outlook & What's Next

Management has guided for 15% volume and EBITDA growth in FY27, with no planned capex in the next two years but potential for strategic acquisitions or capacity partnerships. Cash flow is expected to be allocated toward debt reduction or shareholder returns, underscoring a balanced capital allocation approach. International expansion, particularly in the UK, and continued premiumization of products are central to the growth strategy, with D2C channels playing an increasingly important role in distribution and margin enhancement.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Agricultural Food & other Products

Company MCap (₹ Cr) P/E ROCE ROE D/E
TATA CONSUMER PRODUCTS LIMITED 1.22 L Cr 83.2 9.4% 7.3% 0.09
Marico Limited 1.09 L Cr 67.8
Patanjali Foods Limited 50,036 30.3
AWL Agri Business Limited 25,958 21.8
CCL Products (India) Limited 14,906 54.3
LT Foods Limited 14,215 23.9
Balrampur Chini Mills Limited 10,897 26.5
Triveni Engineering & Industries Limited 8,190 38.6
KRBL Limited 7,756 17.8
Gujarat Ambuja Exports Limited 7,467 24.2

🔗 Peer Stock Analyses

⚠️ Risk Factors

1) Input cost volatility, particularly in raw materials, could pressure margins despite current efficiency gains. 2) Execution risks in international expansion, especially in the UK market, where competition and regulatory dynamics may differ. 3) Dependence on D2C growth as a margin driver introduces concentration risk if consumer adoption slows. 4) Strategic acquisition or partnership execution could face integration or valuation challenges if not managed prudently.

📋 Recent Filings

🧠 Analyst's Read

CCL is executing a clear growth strategy anchored in volume expansion, premiumization, and internationalization, supported by strong financial performance and a healthy balance sheet. Investors should monitor the pace of international revenue contribution and the realization of synergies from strategic initiatives, as these will be critical to sustaining growth momentum beyond FY26.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when CCL files new disclosures

Track CCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CCL — Free

Free account · 2 AI queries/day